Chronic escapable footshock causes a reduced response to morphine in rats as assessed by local cerebral metabolic rates.
The 2-deoxy-D-[14C]glucose (2-DG) method was used to examine the effects of morphine sulfate (MS) on local cerebral metabolic rates for glucose (LCMRglu) in male F-344 rats required to turn a wheel manipulandum in order to escape from nociceptive footshock. This nociceptive stimulus was identical with that utilized in a previous 2-DG study from this laboratory [15] except that animals were exposed to 15 daily 30 min sessions of footshock prior to the 2-DG testing day rather than a single footshock exposure. This allows a direct comparison of the effects of morphine in chronic and acute pain. Unlike the acute footshock study, morphine in chronic footshock rats did not have a significant effect compared with chronic footshock alone in any of the 73 measured brain structures, including limbic and midline thalamic structures previously shown to be important in morphine-induced analgesia during acute pain [15]. Whereas 93% of measured cerebral structures showed decreases in LCMRglu following morphine administration in the acute footshock rats, morphine given to chronic footshock rats caused decreases in only 56% of the structures as compared with chronic footshock plus saline. It is hypothesized that these differential effects of morphine are due in part to a habituation to the chronic stressor such that chronic footshock rats are less stressed than acute footshock rats. Additionally, it is suggested that chronic exposure to pain produces a constant elevation of opioid peptides leading to opioid receptor downregulation and consequently morphine tolerance. These results demonstrate that, even in the presence of the same nociceptive stimulus, morphine can have widely disparate effects on brain metabolism if there are differences in the pain history of the animal.
Gescuk
B D
BD
Laboratory of Behavioral Pharmacology, Boston University School of Medicine, MA 02118, USA.
Lang
S
S
Kornetsky
C
C
D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D000963:Antimetabolites / Q000493:pharmacokinetics; D001362:Avoidance Learning / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects / Q000502:physiology*; D003847:Deoxyglucose / Q000493:pharmacokinetics; D004597:Electroshock; D006400:Hematocrit; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D010146:Pain / Q000378:metabolism; D051381:Rats; D011916:Rats, Inbred F344
D000701:Analgesics, Opioid; D000963:Antimetabolites; D009020:Morphine; D003847:Deoxyglucose